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Asthma is one of the most common chronic 
and disabling conditions of childhood (Bloom 
et al. 2010). The prevalence of asthma in chil‑
dren has risen in the last few decades, currently 
affecting 1 in 10 children (Akinbami et al. 
2011; Bloom et al. 2010). Several environmen‑
tal risk factors for asthma have been identified, 
such as tobacco smoke and airborne pollutants 
(McConnell et al. 2010; Oberg et al. 2011). 
The reasons for the increase in childhood 
asthma are largely unknown, but other envi‑
ronmental exposures may play a role.
Recent studies have implicated exposure 
to plastic products in the development of 
childhood respiratory problems. Investigators 
have found an association of exposure to plas‑
tic wall materials (any plastic wall surfaces) 
with the development of bronchial obstruc‑
tion, persistent wheeze, cough, and phlegm in 
children (Jaakkola et al. 1999, 2000). Jaakkola 
et al. (2006) found that exposure to plastic 
wall materials also was associated with more 
than two times the odds of asthma in adults. 
Indoor concentrations of common organic 
plasticizers (2,2,4‑trimethyl‑1,3‑  pentanediol 
monoisobutyrate and 2,2,4‑trimethyl‑1,3‑
pentanediol diisobutyrate) in schools also 
have been associated with increased preva‑
lence of asthmatic symptoms in students 
(Kim et al. 2007). Thus, the evidence for an 
association between plastic exposures and 
wheeze is growing, but it is unclear whether 
specific plastic constituents, such as bisphe‑
nol A (BPA) or phthalates, act as risk factors 
for childhood respiratory problems.
BPA is a high‑production‑volume chemi‑
cal used in the manufacture of some plastics 
and epoxy resins that are found in many con‑
sumer products. The primary route of human 
exposure to BPA is through dietary ingestion 
(Wilson et al. 2007). Unfortunately, there is 
little information about the variability and 
routes of BPA exposure in pregnant women 
(Braun et al. 2011). BPA was detected in the 
urine of > 90% of the National Health and 
Nutrition Examination Survey (NHANES) 
2003–2004 participants > 6 years of age 
(Calafat et al. 2008). Perinatal BPA exposure 
has been reported to promote experimental 
asthma in mice, but this relationship has not 
been evaluated in humans (Midoro‑Horiuti 
et al. 2010). The objective of this analysis was 
to examine the relationship between prenatal 
BPA exposure and wheeze in early childhood.
Methods
We used data from the Health Outcomes 
and Measures of the Environment (HOME) 
Study for this project (Braun et al. 2009; 
Phelan et al. 2009). The HOME Study is a 
prospective birth cohort with the primary 
goal of investigating the effects of exposure 
to environmental toxicants on child growth, 
neurobehavioral development, and respi‑
ratory health. Between March 2003 and 
January 2006, the HOME Study enrolled 
English‑speaking women at a mean ± SD of 
approximately 16 ± 2 weeks gestation who 
were ≥ 18 years and lived in a home built 
before 1979. We tracked the women through 
pregnancy and are continuing to follow their 
children through 5 years of age. Women 
resided within five Ohio counties surround‑
ing Cincinnati, received prenatal care from 
one of nine participating obstetrical clinics, 
and delivered at one of three participating 
hospitals. The obstetric clinics provided us 
with lists of new patients, and we prescreened 
women for eligibility criteria. We sent study 
information to eligible women and placed a 
follow up phone call to assess interest in the 
study and complete screening. Approximately 
37% (468 of 1,263) of eligible women agreed 
to participate and provided written informed 
consent. We excluded potential participants 
if they were HIV positive, taking antiepileptic 
medication, or were diabetic (not gestational) 
or had bipolar disorder or schizophrenia. 
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Ba c k g r o u n d: Bisphenol A (BPA), an endocrine-disrupting chemical that is routinely detected in 
> 90% of Americans, promotes experimental asthma in mice. The association of prenatal BPA expo-
sure and wheeze has not been evaluated in humans.
oB j e c t i v e: We examined the relationship between prenatal BPA exposure and wheeze in early 
childhood.
Me t h o d s : We measured BPA concentrations in serial maternal urine samples from a prospective 
birth cohort of 398 mother–infant pairs and assessed parent-reported child wheeze every 6 months 
for 3 years. We used generalized estimating equations with a logit link to evaluate the association 
of prenatal urinary BPA concentration with the dichotomous outcome wheeze (wheeze over the 
  previous 6 months).
re s u l t s: Data were available for 365 children; BPA was detected in 99% of maternal urine samples 
during pregnancy. In multivariable analysis, a one-unit increase in log-transformed creatinine-
standardized mean prenatal urinary BPA concentration was not significantly associated with child 
wheeze from birth to 3 years of age, but there was an interaction of BPA concentration with time 
(p = 0.003). Mean prenatal BPA above versus below the median was positively associated with 
wheeze at 6 months of age [adjusted odds ratio (AOR) = 2.3; 95% confidence interval (CI): 1.3, 4.1] 
but not at 3 years (AOR = 0.6; 95% CI: 0.3, 1.1). In secondary analyses evaluating associations of 
each prenatal BPA concentration separately, urinary BPA concentrations measured at 16 weeks 
gestation were associated with wheeze (AOR = 1.2; 95% CI: 1.0, 1.5), but BPA concentrations at 
26 weeks of gestation or at birth were not.
co n c l u s i o n s: Mean prenatal BPA was associated with increased odds of wheeze in early life, and 
the effect diminished over time. Evaluating exposure at each prenatal time point demonstrated an 
association between wheeze from 6 months to 3 years and log-transformed BPA concentration at 
16 weeks gestation only.
key w o r d s : bisphenol A, BPA, child, cotinine, prenatal, tobacco, wheeze. Environ Health Perspect 
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Infants of participating mothers were eligible 
for the longitudinal study. The longitudinal 
study included an embedded randomized 
control trial of a lead hazard reduction inter‑
vention and injury hazard reduction control.
We included only children with prenatal 
urinary BPA concentration and respiratory 
outcome data for this study. These data were 
available for 365 children (92% of HOME 
Study participants: 398 live‑born infants, ran‑
domly excluding one child for twin births). 
The institutional review boards of Cincinnati 
Children’s Hospital Medical Center, the 
Centers for Disease Control and Prevention 
(CDC), and the involved birth hospitals 
approved the HOME Study and this project.
Exposure assessment. We assessed pre‑
natal BPA exposure by measuring the con‑
centrations of BPA in serial maternal spot 
urine samples. We collected maternal urine 
and serum at enrollment (15.9 ± 1.9 weeks 
gestation), 26 weeks gestation, and birth. 
Urine and serum samples were sent to the 
Division of Laboratory Sciences at the CDC 
for analysis. Urinary BPA concentrations were 
quantified using online solid‑phase extrac‑
tion coupled with high‑performance liquid 
  chromatography/isotope‑dilution tandem 
mass spectrometry (Ye et al. 2005a, 2005b). 
The limit of detection (LOD) was 0.4 μg/L. 
When BPA concentrations were below 
the LOD (< 13% of samples), we replaced 
these values with the LOD divided by √
–
2 
(Hornung and Reed 1990).
We assessed tobacco exposure using serum 
concentrations of cotinine, a metabolite of 
nicotine. We used serum cotinine, a biomarker 
of tobacco exposure, as a covariate in analyses 
because of the established association of pre‑
natal tobacco exposure with wheeze in child‑
hood (Sherriff et al. 2001; Spanier et al. 2011). 
Analyses of serum for cotinine were performed 
using high‑performance liquid chromatog‑
raphy/atmospheric‑pressure chemical ioniza‑
tion tandem mass spectrometry (Bernert et al. 
1997, 2000). The LOD was 0.015 ng/mL. 
When serum cotinine values were below the 
LOD (~ 35% of samples), we imputed values 
by sampling randomly from the left tail of a 
lognormal distribution. We collected other 
environmental exposure information (i.e., pet 
ownership, cockroach exposure, and house 
characteristics) by survey as described below.
Outcome measure. After birth, we 
employed trained research assistants to survey 
parents every 6 months through the child’s age 
3 years to collect study data. The baseline, 12‑, 
24‑, and 36‑month surveys were conducted 
via home visits, and the 6‑, 18‑, and 30‑month 
surveys were conducted over the phone. We 
designed these survey questions to parallel the 
NHANES wheeze question (National Center 
for Health Statistics 1994). We asked “Has 
[child’s name] had wheezing or whistling in 
his/her chest in the last 6 months?” We also 
asked about the number of wheeze attacks, 
and we dichotomized the number of wheeze 
attacks at each time point (no wheeze vs. any 
wheeze) to minimize effects of extreme val‑
ues. We used this dichotomized value as our 
outcome measure. We also asked if wheezing 
usually occurred with or followed a cold or 
viral illness.
Covariates. Trained research assistants 
conducted extensive surveys at baseline and 
every 6 months after the child was born to 
collect data on potential covariates, including 
demographic characteristics, socioeconomic 
status, and health status. Demographic and 
socioeconomic characteristics such as mater‑
nal education, race/ethnicity, occupation, 
income, housing volume, and health insur‑
ance status were considered as possible covari‑
ates in all models. We also considered other 
factors potentially associated with wheeze by 
evaluating them as possible covariates [e.g., 
prenatal tobacco exposure (cotinine), season, 
history and duration of breast‑feeding, family 
history of asthma, family history of allergy, 
child eczema, child allergy, neonatal charac‑
teristics, pet ownership, and cockroach expo‑
sure] (Ball et al. 2000; Fleming et al. 1987; 
Gold et al. 1999; Oddy et al. 2002; Simoes 
2003; Taussig et al. 2003; Young et al. 2000).
We categorized residence location/type 
into three categories based on census tract 
information. Family residence was categorized 
as urban if their census tract was located in 
a city defined as a metropolitan area by U.S. 
Census 2000 (Cincinnati, OH; Newport, KY; 
and Covington, KY) (unpublished data), rural 
if their census tract had a 2000 Census popu‑
lation density < 500 persons/square mile, and 
suburban if their census tract did not fit into 
urban or rural categories.
Statistical analysis. We first calculated 
descriptive statistics for all demographic, expo‑
sure, and outcome data. We used a natural log 
transformation for all BPA data because uri‑
nary BPA concentrations were approximately 
log‑normal, and to minimize the influence of 
outlying values. We used the geometric mean 
and 95% confidence interval (CI) as the pri‑
mary descriptors of central tendency and dis‑
persion for BPA data.
We used the mean of creatinine standard‑
ized prenatal urinary BPA concentrations as our 
primary independent variable to approximate 
exposure over pregnancy. To calculate this vari‑
able, we first standardized BPA concentrations 
for urinary creatinine (micrograms of BPA per 
gram of creatinine) at each time point. We then 
calculated the mean of all available standard‑
ized BPA concentrations and log transformed 
the mean of prenatal BPA concentrations for 
each participant. We analyzed the association 
of prenatal urinary BPA concentration with the 
dichotomous outcome variable wheeze (wheeze 
over the previous 6 months) using generalized 
estimating equations (GEEs) with a logit link. 
GEE is an extension of logistic regression that 
accounts for within‑subject correlation result‑
ing from repeated outcome measurements in 
longitudinal studies. Therefore, all data col‑
lected during the six time points (months 6, 12, 
18, 24, 30, and 36) were used in the analysis. 
Interpretation of the association between the 
exposure variable and outcome (i.e., wheeze) 
using odds ratios (ORs) and 95% CIs from 
GEEs is similar to ordinary logistic regression 
but represents the association with wheeze over 
the entire 3‑year period rather than at a single 
point in time. We first conducted bivariate 
analyses to evaluate the association of prenatal 
BPA concentration and potential covariates 
with wheeze. After bivariate analysis, we con‑
ducted a multivariable analysis using forward 
selection techniques. In the initial multivari‑
able analysis, we included covariates that pre‑
dicted wheeze with a p‑value ≤ 0.2 in bivariate 
analysis. Covariates were retained if they were 
significantly associated with wheeze (p < 0.05) 
or if their addition caused a > 10% change in 
the estimate of the association between wheeze 
and prenatal BPA. In all analyses (including 
the bivariate analyses), we included a variable 
for survey time point (6, 12, 18, 24, 30, or 
36 months) and a variable for intervention 
arm to account for any potential design effects 
of the embedded randomized trial. We also 
adjusted for log‑transformed maternal serum 
cotinine (continuous) because previous studies 
have demonstrated an association of cotinine 
with wheeze (Spanier et al. 2011). After con‑
ducting the multivariable analysis, we tested for 
potential multiplicative interactions of prenatal 
BPA concentration with all covariates on the 
logit scale.
We conducted secondary analyses to 
explore potential windows of vulnerability by 
replacing the mean prenatal urinary BPA con‑
centration variable with BPA concentration 
measured at each of the prenatal time points 
(i.e., 16 weeks, 26 weeks, and at birth) in 
three separate analyses, each standardized for 
same time urinary creatinine. GEE analyses 
were used for these secondary analyses. SAS 
(version 9.2; SAS Institute Inc., Cary, NC, 
USA) was used for all data analyses.
Results
More than half of the child participants were 
female (55.6%), most had a white mother 
(65.5%), and most were born full term 
(Table 1). Compared with the 33 participants 
without outcome data, those for whom out‑
come data were available were more likely to 
be white, have a mother with more than a high 
school education, live in non  urban environ‑
ment, have married parents, have an older 
mother, and have a higher household income. 
Of 365 children with maternal prenatal BPA Spanier et al.
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concentration and respiratory outcome data 
available, 99% were born to a mother with 
detectable urinary BPA concentrations at some 
point during pregnancy. The geometric mean of 
the mean prenatal urinary BPA concentration 
was 2.4 μg/g creatinine (95% CI: 2.3, 2.6 μg/g 
creatinine) (Table 2). During the study, the 
frequency of children with wheeze during a 
6‑month period ranged from a low of 15.3% to 
a high of 24% (Figure 1). Almost all wheezing 
episodes occurred in relation to a cold; the fre‑
quency of children who wheezed without a cold 
during any 6‑month period ranged from a low 
of 0% to a high of 2.7% (data not shown).
The prenatal creatinine‑standardized uri‑
nary BPA concentrations measured at 16 weeks 
of gestation, 26 weeks of gestation, and birth 
were only weakly correlated (Pearson’s cor‑
relation coefficients of 0.07, 0.12, and 0.13 for 
the three pairs of measurements). In bivari  ate 
analysis, the OR for a one‑unit change in log‑
transformed mean prenatal BPA concentration 
was 1.16 (95% CI: 0.90, 1.49). In multivari‑
able analysis, adjusting for season, maternal 
allergy, mean prenatal serum cotinine con‑
centration, time (categorical), and interven‑
tion group, log‑transformed mean prenatal 
urinary BPA concentration was not associated 
with wheeze [adjusted OR (AOR) = 1.13; 
95% CI: 0.86, 1.47].
There was a borderline interaction of mean 
prenatal urinary BPA concentration with time 
in the multivariable analysis (p = 0.06). We 
dichotomized prenatal BPA at the median 
(≥ 2.197 vs. < 2.197 μg/g creatinine) to permit 
exploration of the interaction of prenatal BPA 
concentration with time (Table 3). The inter‑
action of dichotomized BPA and time was sig‑
nificant (p = 0.002). At 6 months of age, the 
adjusted odds of wheeze for children born to 
mothers with a BPA concentration above the 
median compared with those born to mothers 
with a BPA concentration below the median 
was 2.27 (95% CI: 1.28, 4.06); by 3 years, 
there was no longer a significant association of 
mean prenatal BPA concentration with wheeze 
(AOR = 0.57; 95% CI: 0.29, 1.10). There was 
no statistically significant interaction (p > 0.05) 
of BPA urinary concentrations with any of the 
other covariates or with sex.
Windows of vulnerability (timing). In sec‑
ondary analyses, we used separate multivari‑
able models to estimate associations of wheeze 
(from birth to 3 years of age) with creatinine‑
standardized log‑transformed maternal uri‑
nary BPA concentration at each time point 
during pregnancy. A one‑unit change in log‑
transformed prenatal urinary BPA concentra‑
tion at 16 weeks of gestation had a borderline 
association with wheeze (AOR = 1.21; 95% 
CI: 0.99, 1.49); wheeze was not associated 
with BPA at 26 weeks of gestation (AOR = 
1.08; 95% CI: 0.87, 1.34) or at birth (AOR 
= 0.91; 95% CI: 0.73, 1. 15). Interactions of 
BPA with time (study time point) were not 
statistically significant in these analyses.
We also explored whether adjusting, rather 
than standardizing, for urinary creatinine 
altered our findings, but the results were simi‑
lar. Specifically, wheeze was associated with a 
one‑unit increase in log‑  transformed pre  natal 
urinary BPA concentration at 16 weeks of ges‑
tation (AOR = 1.24; 95% CI: 1.00, 1.52) but 
not at 26 weeks of gestation (AOR = 1.07; 
95% CI: 0.86, 1.33) or at birth (AOR = 0.89; 
95% CI: 0.71, 1. 12).
Discussion
We evaluated the relationship of prenatal 
BPA exposure, estimated by measuring mater‑
nal urinary BPA concentration, with child‑
hood wheeze in a prospective birth cohort. 
BPA was detected in the urine of virtually all 
of the pregnant women. We found that the 
mean urinary BPA concentration was associ‑
ated with wheeze in children at 6 months of 
age, but there was no evidence of a persis‑
tent positive association by 3 years of age. In 
secondary analyses, we explored windows of 
vulnerability during pregnancy and found an 
association of wheeze with BPA exposure only 
during early pregnancy.
Previous investigators have noted an asso‑
ciation of exposure to plastic wall materials 
with the development of bronchial obstruc‑
tion, adult asthma, and respiratory symptoms 
typical of childhood asthma (Jaakkola et al. 
1999, 2000, 2006; Kim et al. 2007). These 
studies focused on plastic or plasticizers as a 
broad category rather than evaluating spe‑
cific chemicals in plastic. BPA, a chemical 
found in some plastics, promotes the develop‑
ment of experimental asthma in mouse pups, 
and perinatal BPA exposure enhanced aller‑
gic sensitization, airway hyperresponsiveness, 
and bronchial eosinophilic inflammation in 
mice (Midoro‑Horiuti et al. 2010). Similarly, 
Table 1. Characteristics of study participants with available prenatal BPA concentration and wheeze 
data [n (%)].
Characteristic Included Excluded p-Valuea
No. of participants 365 (91.7) 33 (8.3) Not applicable
Male 162 (44.4) 21 (63.6) 0.03
Maternal race
White 239 (65.5) 5 (15.1)
Black 103 (28.2) 18 (54.6) < 0.0001
Other 23 (6.3) 4 (12.1)
Unknown 6 (18.2)
Maternal education
< High school 77 (21.1) 18 (54.5) < 0.0001
≥ Any college 288 (78.9) 9 (27.3)
Unknown 6 (18.2)
Maternal marital status
Married 249 (68.2) 7 (21.2) < 0.0001
Not married 116 (31.8) 20 (60.6)
Unknown 6 (18.2)
Household income
< $25,000 87 (23.8) 15 (45.4)
$25,000–50,000 78 (21.4) 6 (18.2) 0.003
$50,000–80,000 91 (24.9) 1 (3.0)
> $80,000 102 (27.9) 3 (9.1)
Unknown 8 (24.2)
Residence
Rural 12 (3.3) 1 (3.0)
Suburban 133 (36.4) 6 (18.2) 0.04
Urban 220 (60.3) 26 (78.8)
History of maternal allergy 157 (43.0) 11 (40.7) 0.82
Prenatal serum cotinine concentration, 
μg/L [geometric mean (95% CI)]
0.06 (0.04, 0.07) 1.15 (0.41, 3.23) < 0.0001
Gestational age, weeks (mean ± SD) 39.0 ± 1.8 38.0 ± 2.8 0.07
aRepresents a test (chi-square or t-test) of the difference between the children in the included and excluded groups.
Table 2. Prenatal creatinine-standardized urinary 
BPA concentrations (μg/g).
Collection time n
Geometric mean 
(95% CI)
Percent 
> LODa
16 weeks gestation 363 1.9 (1.7, 2.1) 89.8
26 weeks gestation 353 2.2 (2.1, 2.4) 90.4
Birth 330 2.0 (1.9, 2.2) 87.6
Mean prenatal 365 2.4 (2.3, 2.6) 100
aLOD = 0.4 μg/L.
Figure 1. Percentage of children with wheeze over 
previous 6 months in the HOME Study (n = 365).
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we found that prenatal exposure to BPA was 
associated with wheeze in infants.
Nearly all the children in this study were 
born to mothers exposed to BPA during preg‑
nancy, based on urinary BPA concentrations. 
This finding is consistent with NHANES data: 
Urinary BPA was detected in nearly 93% of 
participants > 6 years of age (Calafat et al. 
2008). The geometric mean urinary BPA con‑
centration among women in the HOME Study 
cohort was 2.4 μg/g creatinine, compared with 
2.6 μg/g creatinine reported in NHANES for 
2003–2004 (Calafat et al. 2008).
There are limited human data about the 
bioavailability and metabolism of BPA dur‑
ing pregnancy. It has been demonstrated that 
BPA at low levels can cross the human pla‑
centa in an ex vivo model (Balakrishnan et al. 
2010). It has also been noted that BPA levels 
in human amniotic fluid appear to be higher 
in early pregnancy than in later pregnancy 
(Ikezuki et al. 2002). Unfortunately, we did 
not have direct measures of fetal or amniotic 
BPA concentrations in this study.
We did not find an association between 
mean prenatal urinary BPA concentration and 
wheeze over the entire study period but did 
find evidence of an association with wheeze 
in infancy that decreased over time. This early 
association may be spurious, or it may be 
analo  gous to the transient early wheeze pheno‑
type of pediatric asthma (Martinez et al. 1995).
Our primary measure of prenatal BPA 
exposure was the mean of up to three serial uri‑
nary BPA concentrations standardized for crea‑
tinine at each time point, but we also examined 
windows of vulnerability. Increased urinary 
BPA concentration at 16 weeks of gestation had 
a borderline association with increased odds 
of wheeze during the entire time period from 
6 months to 3 years of age. This finding suggests 
that exposure to BPA in early pregnancy might 
be driving the observed association of mean 
prenatal BPA concentration and wheeze. There 
are no other human respiratory studies to com‑
pare with this result, but it is consistent with 
an evaluation of prenatal BPA exposure and 
child behavior in the same prospective cohort 
that found that 16‑week‑gestation urinary BPA 
concentration was significantly associated with 
externalizing behaviors (Braun et al. 2009).
We found that BPA concentrations from 
the three prenatal urinary measurements were 
weakly correlated. Other biological markers 
such as serum cotinine measured at similar 
intervals during pregnancy demonstrate higher 
correlations (correlation coefficients r ≥ 0.8) 
(Spanier et al. 2011). Despite this weak corre‑
lation some investigators have suggested that 
a single urinary measure of BPA is predictive 
of long‑term exposure (Mahalingaiah et al. 
2008). Other investigators have noted that 
BPA concentrations for an individual vary 
both within and among days (Ye et al. 2011), 
and some suggest that studies may need to 
measure BPA concentration more than once 
during pregnancy (Braun et al. 2011). We 
chose to use mean prenatal urinary BPA con‑
centration as the primary exposure measure to 
represent exposure averaged over pregnancy. 
However, using the mean prohibited us from 
adjusting for time‑specific urinary creatinine, 
which was suggested by Barr et al. (2005). 
Rather than adjusting for urinary creatinine 
in our analyses, we standardized each BPA 
concentration before calculating the mean 
to account for differences in urinary concen‑
tration and kidney filtration. Our use of the 
mean of the maternal urinary BPA concentra‑
tions was a conservative approach that could 
have underestimated associations because it 
averaged several measures. Future work should 
evaluate the best approach for BPA exposure 
assessment throughout pregnancy.
There are several strengths and limitations 
to this study. First, although having serial 
measures of BPA is a strength, it forced us to 
standardize urinary BPA concentration for cre‑
atinine. Some investigators suggest that it may 
be better to adjust for creatinine in the analy‑
sis rather than standardize each time point. 
Adjustment requires inclusion of the creatinine 
and BPA as separate variables in the analysis. In 
this case we have three maternal measures, and 
it would not have been appropriate to place 
the three maternal BPA concentrations and 
the three creatinine concentrations in the same 
analysis. Second, because of the variability of 
urinary BPA concentrations over time, using 
this biomarker could result in exposure misclas‑
sification. Third, our outcome variable, wheeze, 
was based on parent report and could have 
been under‑ or overreported. Fourth, although 
the HOME Study is a representative sample of 
the population in the Cincinnati metropolitan 
area, it is not a random sample. Last, there was 
differential attrition for our cohort; the attri‑
tion rate for minority, low‑income families was 
higher than for white, affluent families. Future 
studies should explore the association of BPA 
exposure with wheeze beyond 3 years of age, 
with objective measures of lung function, and 
with the diagnosis of asthma.
Conclusion
We found that mean prenatal BPA exposure, 
assessed from maternal urinary BPA concen‑
tration, was associated with increased odds of 
wheeze at 6 months of age, but the associa‑
tion diminished by 3 years of age. Evaluating 
BPA exposure at each prenatal measurement 
time demonstrated an association of wheeze 
with BPA at 16 weeks of gestation but not at 
26 weeks of gestation or at birth, which sug‑
gests that early pregnancy may be the most 
sensitive time window of exposure. In the 
analy  ses of each separate prenatal measure‑
ment, there was no evidence that the effect 
diminished across the 3 years. If exposure to 
BPA is confirmed to increase the risk for devel‑
oping wheeze or asthma, it may help explain 
the rising rates of childhood asthma and would 
have important policy implications for women 
of childbearing age and their children.
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